Variant report

Variant	nsv525488
Chromosome Location	chr9:27281151-27283020
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:8)
CpG islands
(count:122)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:8 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr9:27281155-27281334	K562	blood:	n/a	n/a
2	MAX	chr9:27281241-27281340	NB4	blood:	n/a	n/a
3	POLR2A	chr9:27281206-27281321	K562	blood:	n/a	n/a
4	SRF	chr9:27280841-27281290	ECC-1	luminal epithelium:	n/a	n/a
5	SRF	chr9:27280832-27281290	ECC-1	luminal epithelium:	n/a	n/a
6	STAT3	chr9:27281008-27281208	MCF10A-Er-Src	breast:	n/a	n/a
7	STAT3	chr9:27281011-27281243	MCF10A-Er-Src	breast:	n/a	n/a
8	TBP	chr9:27282575-27282757	H1-hESC	embryonic stem cell:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:27282776-27282826	NHDF-neo	bronchial:	n/a
2	chr9:27282580-27282630	NB4	blood:	n/a
3	chr9:27282776-27282826	PANC-1	pancreas:	n/a
4	chr9:27282580-27282630	GM06990	blood:	n/a
5	chr9:27282776-27282826	NB4	blood:	n/a
6	chr9:27282580-27282630	GM19239	blood:	n/a
7	chr9:27282776-27282826	MCF-7	breast:	n/a
8	chr9:27282776-27282826	Caco-2	colon:	n/a
9	chr9:27282776-27282826	H1-hESC	embryonic stem cell:	embryo
10	chr9:27282776-27282826	CMK	blood:	n/a
11	chr9:27282776-27282826	HMEC	breast:	n/a
12	chr9:27282776-27282826	T-47D	breast:	n/a
13	chr9:27282580-27282630	AG09319	gingival:	n/a
14	chr9:27282776-27282826	AG10803	skin:	n/a
15	chr9:27282580-27282630	SK-N-SH_RA	brain:	n/a
16	chr9:27282580-27282630	H1-hESC	embryonic stem cell:	embryo
17	chr9:27282580-27282630	HCM	heart:	n/a
18	chr9:27282580-27282630	GM12892	blood:	n/a
19	chr9:27282580-27282630	AG04450	lung:	fetal
20	chr9:27282776-27282826	AG09319	gingival:	n/a
21	chr9:27282580-27282630	A549	lung:	n/a
22	chr9:27282776-27282826	ECC-1	luminal epithelium:	n/a
23	chr9:27282580-27282630	MCF-7	breast:	n/a
24	chr9:27282776-27282826	HUVEC	blood vessel:	n/a
25	chr9:27282580-27282630	PANC-1	pancreas:	n/a
26	chr9:27282580-27282630	GM12878	blood:	n/a
27	chr9:27282776-27282826	LNCaP	prostate:	n/a
28	chr9:27282580-27282630	PrEC	prostate:	n/a
29	chr9:27282776-27282826	HEK293	kidney:	embryo
30	chr9:27282580-27282630	SKMC	muscle:	n/a
31	chr9:27282580-27282630	SAEC	small airway:	n/a
32	chr9:27282580-27282630	NH-A	brain:	n/a
33	chr9:27282580-27282630	Jurkat	blood:	n/a
34	chr9:27282776-27282826	HNPCEpiC	eye:	n/a
35	chr9:27282776-27282826	K562	blood:	n/a
36	chr9:27282580-27282630	AG09309	skin:	n/a
37	chr9:27282776-27282826	HL-60	blood:	n/a
38	chr9:27282580-27282630	NT2-D1	testis:	n/a
39	chr9:27282776-27282826	HIPEpiC	eye:	n/a
40	chr9:27282776-27282826	GM12878	blood:	n/a
41	chr9:27282776-27282826	PFSK-1	brain:	n/a
42	chr9:27282580-27282630	HUVEC	blood vessel:	n/a
43	chr9:27282580-27282630	HRPEpiC	eye:	n/a
44	chr9:27282776-27282826	NT2-D1	testis:	n/a
45	chr9:27282580-27282630	NHDF-neo	bronchial:	n/a
46	chr9:27282580-27282630	PFSK-1	brain:	n/a
47	chr9:27282580-27282630	Hela-S3	cervix:	n/a
48	chr9:27282776-27282826	AG09309	skin:	n/a
49	chr9:27282776-27282826	HRCEpiC	kidney:	n/a
50	chr9:27282580-27282630	HNPCEpiC	eye:	n/a

No data

Variant related genes	Relation type
LINC00032	TF binding region
LINC00032	CpG island

Extended variants
information (count: 101 )
Associated
traits (count: 122 )

Variant overlapped rSNPs/rCNVs (count:101 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs12343358	chr9:27281151-27281152	Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs75133775	chr9:27281154-27281155	Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs573082523	chr9:27281164-27281165	Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs148606205	chr9:27281175-27281176	Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs368973755	chr9:27281187-27281188	Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs577172003	chr9:27281189-27281190	Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs186175549	chr9:27281202-27281203	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
8	rs117254332	chr9:27281226-27281227	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
9	rs189800782	chr9:27281249-27281250	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
10	rs541920916	chr9:27281252-27281253	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
11	rs4879339	chr9:27281253-27281254	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs560595688	chr9:27281261-27281262	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
13	rs527902983	chr9:27281266-27281267	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
14	rs371089119	chr9:27281270-27281271	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
15	rs570697334	chr9:27281297-27281298	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
16	rs556566580	chr9:27281348-27281349	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
17	rs531910644	chr9:27281355-27281356	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
18	rs571552667	chr9:27281372-27281373	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
19	rs142245126	chr9:27281391-27281392	Weak transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
20	rs550204293	chr9:27281402-27281403	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs146270308	chr9:27281415-27281416	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs139315637	chr9:27281420-27281421	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs554241794	chr9:27281425-27281426	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs566148730	chr9:27281457-27281458	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs75456132	chr9:27281478-27281479	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs377687409	chr9:27281484-27281485	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs78049815	chr9:27281486-27281487	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs35750294	chr9:27281529-27281530	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs180722949	chr9:27281540-27281541	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs116129389	chr9:27281541-27281542	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs144073540	chr9:27281542-27281543	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs376808584	chr9:27281561-27281562	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs541434228	chr9:27281597-27281598	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs79269304	chr9:27281613-27281614	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs527419427	chr9:27281621-27281622	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs146584408	chr9:27281648-27281649	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs573286028	chr9:27281656-27281657	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs10119278	chr9:27281685-27281686	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs186380171	chr9:27281692-27281693	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs565380263	chr9:27281743-27281744	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs573154731	chr9:27281780-27281781	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs550457847	chr9:27281828-27281829	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs191239627	chr9:27281869-27281870	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs182981332	chr9:27281894-27281895	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs540468352	chr9:27281913-27281914	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs116613931	chr9:27281973-27281974	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs555593918	chr9:27281974-27281975	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs566060886	chr9:27282001-27282002	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs374113774	chr9:27282008-27282009	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs188817597	chr9:27282022-27282023	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:122)

Disease	PMID	Source
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Medulloblastoma	21979893	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Chronic myeloid leukemia	21384125	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Acute myeloid leukemia	19651601	CNVD
Coronary Disease	20032323	CNVD
Squamous cell cancer	20885788	CNVD
Hirschsprung''s Disease	21712996	CNVD
Cancer	21732550	CNVD
Gastric cancer	22539939	CNVD
Cancer	21183584	CNVD
T-cell lymphomas	19863542	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Metastatic melanoma	18483359	CNVD
Non-small cell lung cancer	20864512	CNVD
Cervical cancer	21062161	CNVD
Acute myeloid leukemia	16864856	CNVD
Glioblastoma	17090523	CNVD
Lung cancer	16773561	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16774939	CNVD
Bladder cancer	19088036	CNVD
Colorectal cancer	16272173	CNVD
Melanoma	16977458	CNVD
Glioblastoma multiforme	17369134	CNVD
Chagasic megaesophagus	20163722	CNVD
Melanoma	19566914	CNVD
Squamous cell cancer	19047905	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Hodgkin''s lymphoma	18179710	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Acute myeloid leukemia	21251322	CNVD
Oral cancer	21386901	CNVD
Breast cancer	21858162	CNVD
Pancreatic cancer	21811587	CNVD
Barrett''s syndrome	19417022	CNVD
Myelofibrosis	22110671	CNVD
Urothelial cell carcinoma	18451213	CNVD
polycythaemia	22829968	CNVD
Neuroblastoma	21899760	CNVD
Breast cancer	21364760	CNVD
Glioblastoma multiforme	21525872	CNVD
Epilepsy	22083797	CNVD
Cancer	22183965	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:40 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:27276800-27281200	Weak transcription	Primary B cells from peripheral blood	blood
2	chr9:27279400-27282200	Enhancers	Brain Germinal Matrix	brain
3	chr9:27280400-27281600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
4	chr9:27280400-27281800	Enhancers	Primary hematopoietic stem cells short term culture	blood
5	chr9:27280600-27281200	Enhancers	Ovary	ovary
6	chr9:27280600-27281400	Flanking Active TSS	Adipose Nuclei	Adipose
7	chr9:27280600-27281400	Flanking Active TSS	Duodenum Mucosa	Duodenum
8	chr9:27280600-27281400	Enhancers	Fetal Muscle Leg	muscle
9	chr9:27280600-27281400	Enhancers	Small Intestine	intestine
10	chr9:27280600-27281600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
11	chr9:27280600-27281800	Enhancers	Cortex derived primary cultured neurospheres	brain
12	chr9:27280600-27282000	Enhancers	Primary hematopoietic stem cells	blood
13	chr9:27280800-27281400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
14	chr9:27280800-27281400	Enhancers	Gastric	stomach
15	chr9:27280800-27281600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
16	chr9:27280800-27281800	Weak transcription	Lung	lung
17	chr9:27280800-27282000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
18	chr9:27281000-27281200	Flanking Bivalent TSS/Enh	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
19	chr9:27281000-27281200	Weak transcription	Psoas Muscle	Psoas
20	chr9:27281000-27281400	Active TSS	Brain Hippocampus Middle	brain
21	chr9:27281000-27281400	Active TSS	Duodenum Smooth Muscle	Duodenum
22	chr9:27281000-27281800	Active TSS	Osteobl	bone
23	chr9:27281000-27282400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
24	chr9:27281000-27285600	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
25	chr9:27281200-27281400	Bivalent Enhancer	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
26	chr9:27281200-27281400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
27	chr9:27281200-27281400	Flanking Bivalent TSS/Enh	NHEK	skin
28	chr9:27281200-27281600	Bivalent/Poised TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
29	chr9:27281200-27281600	Enhancers	Primary B cells from peripheral blood	blood
30	chr9:27281200-27281600	Enhancers	Psoas Muscle	Psoas
31	chr9:27281200-27281800	Enhancers	GM12878-XiMat	blood
32	chr9:27281400-27281600	Bivalent/Poised TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
33	chr9:27281400-27281600	Bivalent/Poised TSS	NHEK	skin
34	chr9:27281400-27281800	Enhancers	Duodenum Mucosa	Duodenum
35	chr9:27281400-27282000	Enhancers	Adipose Nuclei	Adipose
36	chr9:27281400-27282400	Weak transcription	Gastric	stomach
37	chr9:27281600-27282000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
38	chr9:27281800-27282000	Enhancers	Lung	lung
39	chr9:27282400-27282600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
40	chr9:27282400-27282600	Enhancers	Gastric	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links